PETACH-TIKVA, Israel--(BUSINESS WIRE)--Eltek Ltd. (NASDAQ: ELTK), the leading Israeli manufacturer of advanced flex-rigid circuitry solutions, announced today that it has received orders valued at $490,000. The orders include high-end flex-rigid PCBs (printed circuit boards) for use in advanced medical devices by a US medical equipment manufacturer. The orders are expected to be delivered between October 2011 and February 2012.
These orders are a result of Eltek's continued focus on the medical and defense sectors as part of its growth strategy. Total orders since the beginning of 2011 from this customer amount to $900,000.
Arieh Reichart, President and Chief Executive Officer of Eltek said: "We are proud to have been selected as the supplier of PCBs for use in advanced medical equipment, which reflects the recognition of our high technological capabilities. Eltek is receiving increased recognition by worldwide customers based on the high quality and reliability of its products. According to our long term business plan, we are continuing to focus our efforts on strengthening our position in the medical and defense global markets."
About the Company
Eltek is Israel's leading manufacturer of printed circuit boards, the core circuitry of most electronic devices. It specializes in the complex high-end of PCB manufacturing, i.e., HDI, multilayered and flex-rigid boards. Eltek's technologically advanced circuitry solutions are used in today's increasingly sophisticated and compact electronic products. For more information, visit Eltek's web site at www.eltekglobal.com.
Forward Looking Statement:
Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to statements regarding expected results in future quarters, risks in product and technology development and rapid technological change, product demand, the impact of competitive products and pricing, market acceptance, the sales cycle, changing economic conditions and other risk factors detailed in the Company's Annual Report on Form 20-F and other filings with the United States Securities and Exchange Commission.